Market Research Industry Reports

Eli Lilly and Co (LLY) - Medical Equipment - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Eli Lilly and Co (Lilly) is a healthcare company that discovers, develops and markets human and animal healthcare products. The company offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems, immune disorders, mens health and musculoskeletal problems. It also provides pet medicine, food-safety products and companion animal health products, besides services to the food animal industry. Lilly also has mid-to-late stage pipeline products. The company distributes human pharmaceutical and animal health products through independent wholesale distributors. It also promotes its products through sales representatives and marketing agreements with other pharmaceutical companies. The company offers its products in North America, South America, Europe, South Asia, the Middle East, Africa and North Asia-Pacific. Lilly is headquartered in Indianapolis, Indiana, the US.

Eli Lilly and Co (LLY) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




Eli Lilly and Co, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Eli Lilly and Co, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Eli Lilly and Co, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Eli Lilly and Co, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Eli Lilly and Co, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Eli Lilly and Co, Medical Equipment, Deal Details 12
Asset Purchase 12
Eli Lilly Acquires Two Alzheimers Disease Imaging Agents From Siemens Medical Solutions 12
Venture Financing 14
Veritas Genetics Raises USD30 Million in Series B Financing 14
Millin Enterprises Raises Funds through Series A financing 15
ACEA Biosciences Raises USD30 Million in Venture Financing 16
Microtech Medical Raises Funds through Series A Financing 17
Veritas Genetics Raises USD10 Million in Series A Financing Round 18
Companion Medical Raises USD3.15 Million in Series B Financing 19
Private Equity 20
Lilly Asia Ventures and HighLight Capital Invests USD77 Million in Sansure Biotech 20
Partnerships 21
Eli Lilly and Livongo Health Enter into Partnership 21
Eli Lilly and Co Enters into Co-Development Agreement with Rimidi Diabetes 22
DexCom Enters into Agreement with Eli Lilly 23
Insulet Enters into Co-Development Agreement with Eli Lilly 24
Qiagen Enters into Co-Development Agreement with Eli Lilly for Companion Diagnostic Test 25
Qiagen And Eli Lilly Enter Into Co-Development Agreement For Companion Diagnostic Test 26
Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 27
Corgenix Enters Into Co-Development Agreement With Eli Lilly 28
Insulet Enters Into Co-Development Agreement With Eli Lilly 29
Qiagen Enters Into Co-Development Agreement With Eli Lilly 30
Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests 31
PrimeraDx Enters Into Co-Development Agreement With Eli Lilly 32
Cardinal Health Enters Into Co-Marketing Agreement With Eli Lilly For Amyvid 33
Equity Offering 34
Leap Therapeutics to Raise USD18 Million in Private Placement of Units 34
Eli Lilly and Co - Key Competitors 36
Eli Lilly and Co - Key Employees 37
Eli Lilly and Co - Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Joint Venture 47
Recent Developments 48
Strategy And Business Planning 48
Sep 07, 2017: Lilly Takes Steps To Streamline Business, Invest In New Medicines And Drive Growth 48
Financial Announcements 49
Jan 31, 2018: Lilly Reports Strong Fourth-Quarter and Full-Year 2017 Revenue Growth, Increases 2018 EPS Guidance 49
Dec 13, 2017: Lilly Announces 2018 Financial Guidance and Enhances Outlook Through 2020 55
Oct 24, 2017: Lilly Reports Third-Quarter Results 2017 56
Jul 25, 2017: Lilly Reports Second-Quarter Results 61
Apr 25, 2017: Lilly Reports First-Quarter 2017 Results 65
Jan 31, 2017: Lilly Reports Fourth-Quarter And Full-Year 2016 Results 69
Corporate Communications 75
Mar 09, 2018: Maura Dickler, M.D. To Become Vice President Of Late Phase Development At Lilly Oncology 75
Dec 11, 2017: Kimberly Blackwell, M.D., to become Vice President of Early Phase Development and Immuno-oncology at Lilly Oncology 76
Nov 13, 2017: Lilly Appoints Philip Johnson to Senior Vice President and Treasurer 77
Sep 29, 2017: Lilly Announces Senior Leadership Appointments for Finance, Research & Development and Manufacturing 78
Jun 01, 2017: Derica Rice To Retire As Lilly Chief Financial Officer 79
May 10, 2017: Leigh Ann Pusey Joins Lilly as Senior Vice President of Corporate Affairs and Communications 80
Mar 02, 2017: Lilly Announces Changes In Senior Management 81
Feb 09, 2017: Carolyn R. Bertozzi, Ph.D., Elected To Lilly Board Of Directors 82
Government and Public Interest 83
Apr 04, 2017: Lilly and Ohio University Heritage College of Osteopathic Medicine Partner on Rotation Program for Medical Students 83
Other Significant Developments 84
Sep 25, 2017: Geisinger And Boehringer Ingelheim Collaborate To Create A Predictive Model To Help Improve Health Outcomes For People With Type 2 Diabetes 84
Jun 21, 2017: Eli Lilly And Company Unveils Expanded Biotechnology Center In San Diego 85
May 17, 2017: Cogstate Selected as Preferred Provider to Lillys Alzheimers Disease Platform 86
Jan 05, 2017: Lilly To Adjust Organization And Leadership Structure To Better Align With Growth Opportunities 87
Appendix 88
Methodology 88
About GlobalData 88
Contact Us 88
Disclaimer 88

List Of Tables

List of Tables
Eli Lilly and Co, Medical Equipment, Key Facts, 2017 2
Eli Lilly and Co, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Eli Lilly and Co, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Eli Lilly and Co, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Eli Lilly and Co, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Eli Lilly and Co, Deals By Market, 2012 to YTD 2018 9
Eli Lilly and Co, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Eli Lilly Acquires Two Alzheimers Disease Imaging Agents From Siemens Medical Solutions 12
Veritas Genetics Raises USD30 Million in Series B Financing 14
Millin Enterprises Raises Funds through Series A financing 15
ACEA Biosciences Raises USD30 Million in Venture Financing 16
Microtech Medical Raises Funds through Series A Financing 17
Veritas Genetics Raises USD10 Million in Series A Financing Round 18
Companion Medical Raises USD3.15 Million in Series B Financing 19
Lilly Asia Ventures and HighLight Capital Invests USD77 Million in Sansure Biotech 20
Eli Lilly and Livongo Health Enter into Partnership 21
Eli Lilly and Co Enters into Co-Development Agreement with Rimidi Diabetes 22
DexCom Enters into Agreement with Eli Lilly 23
Insulet Enters into Co-Development Agreement with Eli Lilly 24
Qiagen Enters into Co-Development Agreement with Eli Lilly for Companion Diagnostic Test 25
Qiagen And Eli Lilly Enter Into Co-Development Agreement For Companion Diagnostic Test 26
Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 27
Corgenix Enters Into Co-Development Agreement With Eli Lilly 28
Insulet Enters Into Co-Development Agreement With Eli Lilly 29
Qiagen Enters Into Co-Development Agreement With Eli Lilly 30
Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests 31
PrimeraDx Enters Into Co-Development Agreement With Eli Lilly 32
Cardinal Health Enters Into Co-Marketing Agreement With Eli Lilly For Amyvid 33
Leap Therapeutics to Raise USD18 Million in Private Placement of Units 34
Eli Lilly and Co, Key Competitors 36
Eli Lilly and Co, Key Employees 37
Eli Lilly and Co, Subsidiaries 39
Eli Lilly and Co, Joint Venture 47

List Of Figures

List of Figures
Eli Lilly and Co, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Eli Lilly and Co, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Eli Lilly and Co, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Eli Lilly and Co, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Eli Lilly and Co, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Eli Lilly and Co, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Eli Lilly and Co, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Eli Lilly and Co, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

USD 4795View Report

USD 4795View Report

Eli Lilly and Co (LLY) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Eli Lilly and Co (Lilly) is a healthcare company that discovers, develops and markets human and animal healthcare products. The company offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems,

USD 250View Report

Eli Lilly and Company Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Eli Lilly and Company Company Profile is a detailed strategic and analytical report on Eli Lilly and Company. The 2018 version of the report offers detailed insights into the companys

USD 200View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Apr 2018
No. of Pages :88
Country :United States of America
Category :Medical Devices
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube